Globus Medical Shares Outstanding 2010-2024 | GMED

Globus Medical shares outstanding history from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Globus Medical shares outstanding for the quarter ending September 30, 2024 were 0.138B, a 19.8% increase year-over-year.
  • Globus Medical 2023 shares outstanding were 0.115B, a 11.68% increase from 2022.
  • Globus Medical 2022 shares outstanding were 0.103B, a 0.95% decline from 2021.
  • Globus Medical 2021 shares outstanding were 0.104B, a 2.63% increase from 2020.
Globus Medical Annual Shares Outstanding
(Millions of Shares)
2023 115
2022 103
2021 104
2020 101
2019 102
2018 101
2017 98
2016 96
2015 96
2014 95
2013 94
2012 92
2011 90
2010 91
2009 75
Globus Medical Quarterly Shares Outstanding
(Millions of Shares)
2024-09-30 138
2024-06-30 137
2024-03-31 135
2023-12-31 115
2023-09-30 115
2023-06-30 102
2023-03-31 102
2022-12-31 103
2022-09-30 101
2022-06-30 103
2022-03-31 104
2021-12-31 104
2021-09-30 104
2021-06-30 103
2021-03-31 102
2020-12-31 101
2020-09-30 100
2020-06-30 98
2020-03-31 102
2019-12-31 102
2019-09-30 102
2019-06-30 102
2019-03-31 101
2018-12-31 101
2018-09-30 102
2018-06-30 102
2018-03-31 100
2017-12-31 98
2017-09-30 98
2017-06-30 98
2017-03-31 97
2016-12-31 96
2016-09-30 96
2016-06-30 96
2016-03-31 96
2015-12-31 96
2015-09-30 96
2015-06-30 96
2015-03-31 96
2014-12-31 95
2014-09-30 95
2014-06-30 95
2014-03-31 95
2013-12-31 94
2013-09-30 94
2013-06-30 94
2013-03-31 94
2012-12-31 92
2012-09-30 93
2012-06-30 91
2012-03-31 91
2011-12-31 90
2011-09-30 90
2011-06-30 75
2011-03-31 76
2010-12-31
2009-12-31
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $11.291B $1.568B
Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. The spine products address the vast majority of conditions affecting the spine including degenerative conditions, deformity, tumors and trauma. Enabling Technologies are designed to enhance a surgeon's capabilities and streamline the complicated surgical procedures to be safer, less invasive, accurate and more reproducible to improve patient care and reduce radiation exposure for both patient and caregiver. The technology contains imaging, navigation and robotic assisted surgery solutions. It acquired all assets of StelKast, Inc. and Finnish engineering company Synoste Oy.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $205.491B 25.07
Intuitive Surgical (ISRG) United States $191.931B 100.35
Alcon (ALC) Switzerland $42.651B 28.54
Edwards Lifesciences (EW) United States $41.817B 26.55
IQVIA Holdings (IQV) United States $37.469B 20.64
IDEXX Laboratories (IDXX) United States $36.904B 43.46
DexCom (DXCM) United States $30.627B 46.12
Waters (WAT) United States $23.276B 34.42
STERIS (STE) Ireland $21.284B 24.50
SONOVA HOLDING (SONVY) Switzerland $20.097B 0.00
Hologic (HOLX) United States $17.200B 18.58
Fresenius Medical Care AG KGaA (FMS) Germany $14.078B 14.45
Sysmex ADR (SSMXY) Japan $13.104B 41.09
Penumbra (PEN) United States $9.244B 90.55
Masimo (MASI) United States $9.076B 43.92
Teleflex (TFX) United States $8.687B 13.85
Glaukos (GKOS) United States $7.647B 0.00
PROCEPT BioRobotics (PRCT) United States $4.828B 0.00
Integer Holdings (ITGR) United States $4.639B 26.30
Veracyte (VCYT) United States $3.314B 99.44
Inari Medical (NARI) United States $3.126B 0.00
LivaNova (LIVN) United Kingdom $2.714B 15.67
Nihon Kohden (NHNKY) Japan $2.347B 17.83
TransMedics (TMDX) United States $2.344B 74.30
Elekta AB (EKTAY) Sweden $2.216B 19.92
Tandem Diabetes Care (TNDM) United States $2.108B 0.00
Integra LifeSciences Holdings (IART) United States $1.881B 9.83
RxSight (RXST) United States $1.599B 0.00
Alphatec Holdings (ATEC) United States $1.363B 0.00
Artivion (AORT) United States $1.216B 80.56
Pulse Biosciences (PLSE) United States $1.152B 0.00
OPKO Health (OPK) United States $1.078B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.852B 14.48
Paragon 28 (FNA) United States $0.837B 0.00
Mesa Laboratories (MLAB) United States $0.712B 16.78
ORTHOFIX MEDICAL INC (OFIX) United States $0.699B 0.00
IRadimed (IRMD) United States $0.693B 37.47
AxoGen (AXGN) United States $0.646B 0.00
Pacific Biosciences Of California (PACB) United States $0.597B 0.00
SiBone (SIBN) United States $0.570B 0.00
OrthoPediatrics (KIDS) United States $0.544B 0.00
Semler Scientific (SMLR) United States $0.515B 30.30
Treace Medical Concepts (TMCI) United States $0.493B 0.00
Tactile Systems Technology (TCMD) United States $0.441B 23.84
ClearPoint Neuro (CLPT) United States $0.404B 0.00
Delcath Systems (DCTH) United States $0.370B 0.00
AngioDynamics (ANGO) United States $0.351B 0.00
CVRx (CVRX) United States $0.331B 0.00
NeuroPace (NPCE) United States $0.327B 0.00
Inogen (INGN) United States $0.227B 0.00
Alpha Tau Medical (DRTS) Israel $0.215B 0.00
Accuray (ARAY) United States $0.210B 0.00
Sight Sciences (SGHT) United States $0.203B 0.00
KORU Medical Systems (KRMD) United States $0.187B 0.00
Nevro (NVRO) United States $0.163B 0.00
Atossa Genetics (ATOS) United States $0.157B 0.00
Sensus Healthcare (SRTS) United States $0.143B 15.26
Spectral Diagnostics (EDTXF) Canada $0.105B 0.00
WORK Medical Technology Group (WOK) China $0.094B 0.00
LENSAR (LNSR) United States $0.090B 0.00
Vicarious Surgical (RBOT) United States $0.089B 0.00
Monogram Orthopaedics (MGRM) United States $0.084B 0.00
EDAP TMS S.A (EDAP) France $0.084B 0.00
908 Devices (MASS) United States $0.083B 0.00
InspireMD (NSPR) Israel $0.082B 0.00
Hyperfine (HYPR) United States $0.073B 0.00
Covalon Technologies (CVALF) Canada $0.071B 0.00
EnVVeno Medical (NVNO) United States $0.053B 0.00
Lucid Diagnostics (LUCD) United States $0.048B 0.00
Rapid Micro Biosystems (RPID) United States $0.045B 0.00
Envoy Medical (COCH) United States $0.044B 0.00
Spectral AI (MDAI) United States $0.038B 0.00
Accelerate Diagnostics (AXDX) United States $0.038B 0.00
Neuronetics (STIM) United States $0.035B 0.00
Adagio Medical Holdings (ADGM) United States $0.034B 0.00
Precision Optics (POCI) United States $0.032B 0.00
NexGel (NXGL) United States $0.025B 0.00
DarioHealth (DRIO) United States $0.023B 0.00
Biosig Technologies (BSGM) United States $0.019B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Ekso Bionics Holdings (EKSO) United States $0.015B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.015B 0.00
Aspira Women's Health (AWH) United States $0.012B 0.00
Baird Medical Investment Holdings (BDMD) $0.012B 0.00
T2 Biosystems (TTOO) United States $0.011B 0.00
QT Imaging Holdings (QTI) United States $0.011B 0.00
PAVmed (PAVM) United States $0.009B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
Nuwellis (NUWE) United States $0.006B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.005B 0.00
Check-Cap (CHEK) Israel $0.004B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
ReShape Lifesciences (RSLS) United States $0.004B 0.00
Nanovibronix (NAOV) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00